Psoriatic Alopecia/Alopecia Areata‐Like Reactions Secondary to Anti‐Tumour Necrosis Factor‐Alpha Therapy
Year: 2025
Type: article
Study design: Case Report
Abstract: Anti-tumour necrosis factor (TNF) agents have improved the quality of life for many individuals with autoimmune conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. A rarer emerging adverse cutaneous reaction of the drug is the development of psoriasiform alopecia areata, which may present acutely or be delayed for many months to years. This case series will highlight histopathological features pertinent for diagnosis, help distinguish secondary reactions from primary psoriatic alopecia, and help guide management, resulting in less inappropriate discontinuation of therapy.
DOI: 10.1111/ajd.14591
Authors: Lucinda Liu, Ethan La, Tommy Vo, Jacinta Chronowski‐Wong, Tim Khamu, Lachlan Warren, Alain Tran
Language: English
Topic: Hair Growth and Disorders
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,160
Funder: University of Adelaide
OpenAlex ID: W4413355953
